Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions

• Main Authors: Meera Varshneya (Author), Itziar Irurzun-Arana (Author), Chiara Campana (Author), Rafael Dariolli (Author), Amy Gutierrez (Author), Taylor K. Pullinger (Author), Eric A. Sobie (Author)
• Format: Book
• Published: Wiley, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Many drugs that have been proposed for treatment of coronavirus disease 2019 (COVID‐19) are reported to cause cardiac adverse events, including ventricular arrhythmias. In order to properly weigh risks against potential benefits, particularly when decisions must be made quickly, mathematical modelin...